In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk.

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

Oregon Health & Science University researchers have developed a first-of-its-kind method to predict cancer patient survival ...

A research team led by The Hong Kong University of Science and Technology (HKUST) has developed a pioneering artificial ...

Cancer immunology is advancing rapidly as researchers seek to unravel the complex, dynamic relationships between tumor cells, immune populations, and the ...

Cancer clues in pleural effusions are often rare, fragile, and easy to miss. Single malignant tumor cells (MTCs) can help ...

A lab in Hawaiʻi is developing nanobodies, tiny proteins that help the immune system recognize and destroy cancer cells, ...

The honorees are scheduled to deliver lectures during this year’s meeting in San Diego, CA, which runs from April 17-22.

71% of high glyphosate counties have late-stage non-Hodgkin lymphoma rates above the national average High glyphosate use is linked to elevated rates of non-Hodgkin lymphoma cancer, particularly in ...

Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials Total ...

At least 20,000 Australian women are diagnosed with breast cancer each year. And more than 3,300 die from the disease. To save women’s lives, we need to detect breast cancer early. Breast screening, ...